作者:Yuli Xie、Yidong Liu、Gangli Gong、Deborah H. Smith、Fang Yan、Alison Rinderspacher、Yan Feng、Zhengxiang Zhu、Xiangpo Li、Shi-Xian Deng、Lars Branden、Dušica Vidović、Caty Chung、Stephan Schürer、Christophe Morisseau、Bruce D. Hammock、Donald W. Landry
DOI:10.1016/j.bmcl.2008.09.066
日期:2009.4
Soluble epoxide hydrolase (sEH) is a novel target for the treatment of hypertension and vascular inflammation. A new class of potent non-urea sEH inhibitors was identified via high throughput screening (HTS) and chemical modification. IC(50)s of the most potent compounds range from micromolar to low nanomolar. (C) 2008 Elsevier Ltd. All rights reserved.